Check out our report detailing the use of the hemoglobin-based oxygen carrier HBOC-201 in a patient with Ph+ ALL undergoing induction who had anti-Rh 17 antibodies! #leusm

onlinelibrary.wiley.com/doi/10.1111/tr…

appreciate the opportunity from the deeply talented Joshua Fein and Mohammad Alhomoud to join new york's hottest club (podcast) Chimerically Speaking !

Check out this new paper by Michael Drazer on FLT3 agonists and secondary heme malignancies!

pubmed.ncbi.nlm.nih.gov/38652676/

High impact paper on drug responses in ALL featuring Wendy Stock as co-author!

pubmed.ncbi.nlm.nih.gov/38593781/

We care about AML Patients and Families!
Want to learn more about AML, or Acute Myeloid Leukemia? Here's a webinar recording just for you: aamds.org/webinar/ask-am…
#AML #acuteleukemia

New publication in The Lancet Haematology with Toyosi Odenike as co-author focused on clinical trial endpoints in myelofibrosis!

pubmed.ncbi.nlm.nih.gov/38604205/

Attending on our inpt leukemia service for the next 2 weeks! I'll be posting daily articles

Day 1: dose-adjusted 10403 in non-AYA patients with ALL

onlinelibrary.wiley.com/doi/10.1002/jh…

New publication in Blood Advances featuring Wendy Stock as co-author focused on response to inotuzumab based on molecular features!

pubmed.ncbi.nlm.nih.gov/38607410/

We had a *wonderful* time speaking with Mariam Nawas about the wealth of inspiring #bmtsm allo data from #Tandem24 + treating #TP53mut dz. Next episode, coming soon to your favorite podcast app...

Subscribe to never miss an episode!
podcasts.apple.com/us/podcast/chi…
open.spotify.com/show/1US8kq4xe…

What happens when germline predisposition and BMT collide? There often isn’t enough time for donor germline eval before allo. We developed an institutional roadmap with some novel, practical diagnostic maneuvers University of Chicago Hematology/Oncology. Michael Drazer Mariam Nawas

haematologica.org/haematologica/…

Please consider joining us. We are so very excited about our speakers this year!!! #ayacsm

Hot off the press study with Adam DuVall MD, MPH as senior author!

pubmed.ncbi.nlm.nih.gov/38569163/

New study out featuring Dr Larson as co-author in Blood Neoplasia!

Phase III study of devimistat in combination with chemo for R/R AML

sciencedirect.com/science/articl…

I’m thrilled to announce that National Cancer Institute renewed our designation as a Comprehensive Cancer Center for the high-impact work we do for cancer patients and the community. ow.ly/HUOc50R5Jut #NothingWillStopUs #WeAreNCIDesignated #UChiCancer50
Kunle Odunsi, MD

Always a thrill to see a mentee get an abstract accepted for presentation! Looking forward to sharing more about work led by Leah Goldberg & Anjani Kapadia once ASCO abstracts are fully available!

Happy #DoctorsDay to all of the incredible physicians in our Section & across the medical system!! We appreciate you and the care, innovation, and expertise you bring to your work every day!

Excited to speak at the UChicagoCancerCenter Development Therapeutics Conference in a few weeks with a terrific lineup of speakers!

Ben Derman Rajat Thawani Joseph W. Franses MD-PhD Dan Olson Toyosi Odenike

…lopmentaltherapeutics.squarespace.com/agenda

The Dept. of Pathology at the University of Chicago is hiring full-time faculty members to serve as Director and Asst Director of the Transplant Immunology and Immunogenetics Laboratory

Learn more/apply at:
apply.interfolio.com/140784
apply.interfolio.com/139691
EOE/Vet/Disability

🎥 In a recent interview, Caner Saygin, MD of The University of Chicago discusses the impact of clonal hematopoiesis on the outcomes of patients with ALL.

Click here to watch:

👉 ow.ly/XCUY50QXFxY

#ALLsm #Leusm #Leukemia #ESHAL2024 ESH (Haematology) #HemOnc

Check out this comprehensive review in Blood Journal featuring one of our amazing hematopathologists Dr. Gurbuxani!

ashpublications.org/blood/article/…